| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/28/2004 | US20040214225 Immunoglobulin polypeptide for use as diagnostic tool in detecting variable major protein (VMP) of lymes disease; immunodiagnostics and genetic vaccines preventing parasitic infection |
| 10/28/2004 | US20040214223 Methods and agents for screening for compounds capable of modulating VEGF expression |
| 10/28/2004 | US20040214214 Nucleotide sequences coding obesity polypeptide for use in the diagnosis and treatment of viral, cell proliferative weight control and eating disorders |
| 10/28/2004 | US20040214212 Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer |
| 10/28/2004 | US20040214209 Receptor protein for use as tool in kit for detection of immunoglobulins |
| 10/28/2004 | US20040214208 Enterococcal virulence factors |
| 10/28/2004 | US20040214207 Using methylation profile of cytokine receptor gene to detect tumor, skin, ateriosclerotic, arthritic, restonotic and vision disorders |
| 10/28/2004 | US20040214195 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 10/28/2004 | US20040214192 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis |
| 10/28/2004 | US20040214191 Nucleotide sequences coding ganosine triphosphatase ligand for use in diagnosis and treatment of cell proliferative disorders |
| 10/28/2004 | US20040214190 Mammalian c-type lectins |
| 10/28/2004 | US20040214189 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
| 10/28/2004 | US20040214188 Diagnosis and treatment of diabetic , muscle, metabolic and eating disorders |
| 10/28/2004 | US20040214187 Nucleotide sequences coding immunoglobulin orphan receptor (OXR) for use in identifying modulators for treatment of atherosclerosis, arthritis, multiple sclerosis, thrombosis, graft rejection and graft versus host disease |
| 10/28/2004 | US20040214185 Regulatory nucleotide sequence fro use as tools in controlling heterologous/endogenous transcription; transcriptional regulators and bioreactors |
| 10/28/2004 | US20040214184 Amino acid sequences of carcinoembryonic antigen cell adhesion molecule for use as modulaor in treatment of cell proliferative disorders; mimetics |
| 10/28/2004 | US20040214173 Anti-listeria bacteriocin |
| 10/28/2004 | US20040214172 Sheeplice, bovicola ovis, allergen treatment |
| 10/28/2004 | US20040214169 Method of judging flocculating properties of bottom brewer's yeast |
| 10/28/2004 | US20040214167 NF-kappa B activating gene |
| 10/28/2004 | US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 10/28/2004 | US20040214163 Expression vector coding hepatitis c or lymphoma viral nucleotide sequences for use as tool in generating antibodies for use in kit which detects viral infection; vircides and immunotherapy |
| 10/28/2004 | US20040214155 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 10/28/2004 | US20040213810 preparations of bacterial ghosts which are substantially free of living bacterial cells and/or nucleic acids and their use in pharmaceutical preparations |
| 10/28/2004 | US20040213808 immunogenic compositions containing as active ingredients recombinantly-produced forms of truncated flavivirus envelope and non-structural glycoproteins; may also include an adjuvant, such as saponin or a saponin-like material |
| 10/28/2004 | US20040213807 Use of Parapox B2L protein to modify immune responses to administered antigens |
| 10/28/2004 | US20040213806 Salmonella typhi vaccine compositions |
| 10/28/2004 | US20040213805 Deletions in arterivirus replicons |
| 10/28/2004 | US20040213803 a polypeptide conjugated to a Streptococcus pneumoniae capsular polysaccharide; an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity; vaccine; genetic vaccine; antigen |
| 10/28/2004 | US20040213802 Gene of novel corynebacterium diphtheriae antigen |
| 10/28/2004 | US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry |
| 10/28/2004 | US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis |
| 10/28/2004 | US20040213790 VEGF-related protein |
| 10/28/2004 | US20040213787 Vascular Endothelial Growth Factors (VEGF) by injection; for decreased serum glucose concentrations, improved glucose tolerance, increased insulin sensitivity, and reduced hyperinsulinemia |
| 10/28/2004 | US20040213781 testing compounds for their ability to act as an Fc receptor antagonist; antagonist compounds identified by the method; detecting, removing immunoglobulin; rheumatoid arthritis |
| 10/28/2004 | US20040213780 Methods and compositions for treating polyglutamine expansion-associated disease |
| 10/28/2004 | US20040213778 a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; used to elicit a humoral or cellular immune response; antibodies or T cells reactive used in active or passive immunization |
| 10/28/2004 | US20040213772 Peptide factor |
| 10/28/2004 | US20040213771 Targets and screens for agents useful in controlling parasitic nematodes |
| 10/28/2004 | US20040213764 Adenovirus replication-competent vectors expressing trail |
| 10/28/2004 | US20040213763 administering intravenously to the mammal an adenoviral vector comprising a DNA sequence encoding a leptin operably linked to a promoter and expressing the DNA sequence, for treating obesity in a mammal having a deficiency in functional leptin |
| 10/28/2004 | US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3 |
| 10/28/2004 | US20040213753 administrating to a skin or hair of a candidate a sponge protein hydrolysate which is a product by acidic hydrolysis of sponge skeleton fibers (spongin fibers) obtained from refined sponges as the raw material in an amount effective to stimulate cell growth of the skin or hair |
| 10/28/2004 | US20040213738 CIRL3-Like proteins, nucleic acids, and methods of modulating CIRL3-L-mediated activity |
| 10/28/2004 | US20040211865 Sterol carrier protein-2 from the mosquito, Aedes aegypti |
| 10/28/2004 | DE10043937B4 Herstellung einer dreiwertigen Chromkomplexverbindung und eines selbige enthaltenden Milchprodukts Producing a trivalent chromium complex compound and a selbige containing milk product |
| 10/28/2004 | CA2525640A1 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses |
| 10/28/2004 | CA2522985A1 Means and methods for diagnosing and treating affective disorders |
| 10/28/2004 | CA2522680A1 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
| 10/28/2004 | CA2522525A1 Chimeric polypeptides comprising a type ii restriction endonuclease |
| 10/28/2004 | CA2522238A1 S. pneumoniae antigens |
| 10/28/2004 | CA2522221A1 Immunogen, composition for immunological use, and method of producing a ntibody using the same |
| 10/28/2004 | CA2522082A1 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2522060A1 Fragments of fluorescent proteins for protein fragment complementation assays |
| 10/28/2004 | CA2521965A1 Somatostatin-dopamine chimeric analogs |
| 10/28/2004 | CA2521809A1 Improved heat shock protein-based vaccines and immunotherapies |
| 10/28/2004 | CA2521808A1 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 10/28/2004 | CA2521754A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 10/28/2004 | CA2521744A1 Tumor antigens bfa-5 for prevention and/or treatment of cancer |
| 10/28/2004 | CA2521381A1 Method for preparation of site-specific protein conjugates |
| 10/28/2004 | CA2521174A1 Enhanced hiv-1 vaccines and methods for their use |
| 10/28/2004 | CA2463487A1 Tumours treating combinations, compositions and methods |
| 10/27/2004 | EP1471150A2 Plasmodium falciparum antigens inducing protective antibodies |
| 10/27/2004 | EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein |
| 10/27/2004 | EP1471146A2 A packaging cell line expressing for use in facilitating the development of high capacity adenoviral vectors |
| 10/27/2004 | EP1471145A2 Pesticipal proteins and strains |
| 10/27/2004 | EP1471144A1 Biological variability of asthma associated factor, AAF2 (IL-9 receptor), useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 10/27/2004 | EP1471143A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 10/27/2004 | EP1471142A1 Heterodimeric receptor libraries using phagemids |
| 10/27/2004 | EP1471075A2 Human nucleic acid sequences expressed in pancreatic carcinomas |
| 10/27/2004 | EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents |
| 10/27/2004 | EP1471073A2 Hepatitis C virus asialoglycoproteins |
| 10/27/2004 | EP1471072A1 18 human secreted proteins |
| 10/27/2004 | EP1470825A1 Reagents for detecting efavirenz |
| 10/27/2004 | EP1470423A2 Unc-13 in the modulation of neurotransmission and secretion events |
| 10/27/2004 | EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 10/27/2004 | EP1470419A1 Method for monitoring and prognosis of disease course of gastrointestinal tumors |
| 10/27/2004 | EP1470249A2 Effectors of innate immunity |
| 10/27/2004 | EP1470238A2 Novel nucleic acids and polypeptides |
| 10/27/2004 | EP1470236A2 Methods and compositions for protein expression and purification |
| 10/27/2004 | EP1470233A1 Adenoviral vectors for modulating the cellular activities associated with pods |
| 10/27/2004 | EP1470232A1 Physiologically regulated erythropoietin-expressing vector for the treatment of anaemia |
| 10/27/2004 | EP1470229A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 10/27/2004 | EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 10/27/2004 | EP1470222A2 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 10/27/2004 | EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes |
| 10/27/2004 | EP1470216A2 Hair follicle growth |
| 10/27/2004 | EP1470158A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 10/27/2004 | EP1470156A2 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease |
| 10/27/2004 | EP1470155A2 Pluripotency determining factors and uses thereof |
| 10/27/2004 | EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 10/27/2004 | EP1470152A1 Peptides for increasing transfection efficiency |
| 10/27/2004 | EP1470115A1 Treatment of male sexual dysfunction |
| 10/27/2004 | EP1470114A1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 10/27/2004 | EP1469883A2 Compositions and methods for regulating lymphocyte activation |
| 10/27/2004 | EP1469881A2 Vaccine adjuvant based on a cd40 ligand |
| 10/27/2004 | EP1469878A2 Fgfr agonists |